Guillain–Barré syndrome and Fisher syndrome: Case definitions and guidelines for collection, analysis, and presentation of immunization safety data☆
Section snippets
Need for developing a standardized case definition and guidelines for Guillain–Barré syndrome (GBS) and Fisher syndrome (FS) as an adverse event following immunization
Among the various events reported as adverse outcomes following immunizations, neurologic adverse events following immunization (AEFI) are among the most severe and the most difficult to assess. The multifaceted presentation of neurologic illness, the relative lack of familiarity of many clinicians with the approach to and diagnosis of neurologic disease, and the relative scarcity of trained neurologists in many parts of the world make neurologic AEFI some of the most challenging issues in
Clinical case definitions: Guillain–Barré syndrome (GBS)3,4,5
Level 1 of diagnostic certainty
- •
Bilateral AND flaccid weakness of the limbs6,7,8
- •
Guidelines for data collection, analysis, and presentation of GBS and FS as adverse events following immunization
It was the consensus of the Brighton GBS Working Group to recommend the following guidelines to enable meaningful and standardized collection, analysis, and presentation of information about GBS and FS23. However, the implementation of all guidelines might not be possible in all settings. The availability of information may vary depending upon resources, geographic
Acknowledgements
The authors are grateful for the support and helpful comments from members of Brighton Collaboration Steering Committee during the time of the development of this document, who are not already included as authors (Mike Blum, Paul Heath, Hector Izurieta, Brigitte Keller Stanislawski, Katrin Kohl Odile Leroy), and the participants in the Reference Group (Adam Rudiger, Adderson Elisabeth, Aguilar Maria, Aldrovandi Grace, Allen Mary, Bachtiar Novilia Sjafri, Barami A. A. Salim, Baxter Roger,
References (85)
- et al.
The development of standardized case definitions and guidelines for adverse events following immunization
Vaccine
(2007) - et al.
Guillain–Barre syndrome
Lancet
(2005) - et al.
Pathogenesis of Guillain–Barre syndrome
J Neuroimmunol
(1999) - et al.
Multiple pathways to induction of virus-induced autoimmune demyelination: lessons from Theiler's virus infection
J Autoimmun
(2001) - et al.
Diagnostic criteria for the Guillain–Barre syndrome. An analysis of 50 cases
J Neurol Sci
(1971) - et al.
Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-Analyses
Lancet
(1999) - et al.
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
J Clin Epidemiol
(2008) - et al.
A local reaction at or near injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data
Vaccine
(2008) The immunobiology of Guillain–Barre syndromes
J Peripher Nerv Syst
(2005)Guillain–Barre syndrome: historical aspects
Ann Neurol
(1990)
The epidemiology of Guillain–Barre syndrome
Ann Neurol
Epidemiology of the Guillain–Barre syndrome
Curr Opin Neurol
The epidemiology of Guillain–Barre Syndrome worldwide. A systematic literature review
Neuroepidemiology
Epidemiology of Guillain–Barre syndrome
Adv Neurol
Clinical and epidemiologic features of Guillain–Barre syndrome
J Infect Dis
Respiratory dysfunction in Guillain–Barre syndrome
Neurocrit Care
Long-term outcome in patients with Guillain–Barre syndrome requiring mechanical ventilation
Neurology
Guillain–Barre syndrome
Guillain–Barre syndrome in children
Curr Opin Pediatr
Guillain–Barre syndrome in children
J Child Neurol
Prognostic factors in Guillain–Barre’ syndrome
J Assoc Phys India
Epidemiological study of Guillain–Barre syndrome in south east England
J Neurol Neurosurg Psychiatry
New concepts of Guillain–Barre syndrome
J Child Neurol
Guillain–Barre syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases
Brain
Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China
Ann Neurol
Recent developments in Miller Fisher syndrome and related disorders
Curr Opin Neurol
Miller Fisher syndrome: a hospital-based retrospective study
Eur Neurol
Electrophysiological classification of Guillain–Barre syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain–Barre Syndrome Trial Group
Ann Neurol
Pathology of the motor-sensory axonal Guillain–Barre syndrome
Ann Neurol
Anti-GQ1b IgG antibody activities related to the severity of Miller Fisher syndrome
Neurol Res
Campylobacter jejuni infection and Guillain–Barre syndrome
N Engl J Med
Improved serological diagnosis stresses the major role of Campylobacter jejuni in triggering Guillain–Barre syndrome
Clin Vaccine Immunol
The spectrum of antecedent infections in Guillain–Barre syndrome: a case-control study
Neurology
Haemophilus influenzae has a GM1 ganglioside-like structure and elicits Guillain–Barre syndrome
Neurology
Infectious agents as the triggers for the pathogenesis of the neuroimmunological disorders
Nippon Rinsho
Acute motor axonal neuropathy after Mycoplasma infection: evidence of molecular mimicry
Neurology
Influenza, Campylobacter and Mycoplasma infections, and hospital admissions for Guillain–Barre syndrome, England
Emerg Infect Dis
Acute motor and sensory axonal neuropathy in Burkitt-like lymphoma
Muscle Nerve
Neurologic complications after surgery for obesity
Muscle Nerve
Molecular mimicry: cross-reactive antibodies from patients with immune-mediated neurologic disease inhibit neuronal firing
J Neurosci Res
Neuronal molecular mimicry in immune-mediated neurologic disease
Ann Neurol
Cited by (476)
Diagnostic odyssey of Guillain-Barré syndrome in children
2024, Brain and DevelopmentMiller Fisher syndrome: A challenging case for differential diagnosis
2024, Neurologia ArgentinaHigh risk and low prevalence diseases: Guillain-Barré syndrome
2024, American Journal of Emergency MedicinePredictors of long-term health-related quality of life in Guillain-Barré syndrome: A hospital-based study
2023, Clinical Neurology and NeurosurgeryPrognostic Implications of Early Albuminocytological Dissociation in Guillain-Barré Syndrome
2023, Canadian Journal of Neurological Sciences
- ☆
The findings, opinions, conclusions, and assertions contained in this consensus document are those of the individual members of the Working Group. They do not necessarily represent the official positions of each participant's organization (e.g., government, university, or corporations). The findings and conclusions in this paper have not been formally disseminated by the U.S. Centers for Disease Control and Prevention or the U.S. Food and Drug Administration, and should not be construed to represent any Agency determination or policy.
- 1
Retired.
- 2
Homepage of the Brighton Collaboration: http://www.brightoncollaboration.org.